drugset
drugset / Trial / NCT05652816

Biological Skin Graft With Keratinocyte-stem Cell Co-cultre for Burn Patients

NCT05652816 ↗

Phase 0 Unknown 20 enrolled Indonesia University
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to test whether artificial skin graft can substitute autologous skin graft in current burn treatment. The main question it aims to answer is: • Can artificial skin graft result in better wound healing compared to the current burn treatment; autologous skin graft? You will: * Undergo debridement surgery * Receive artificial skin graft as an alternative to autologous skin graft * Undergo biopsy procedure of burn area If there is a comparison group: Researchers will compare autologous skin graft group to see the wound healing process

Timeline

Start
2022-09-06
Primary completion
2023-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Artificial skin graft Unknown — —
Subject Artificial skin graft co-culture Cell therapy — —

Indications

No indication recorded.